NCT03296423View on ClinicalTrials.gov

Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 21, 2017

Primary Completion Date

August 31, 2020

Study Completion Date

November 30, 2020

Conditions
InfectionHospitalizationMortality
Interventions
BIOLOGICAL

Vaccination

Patients discharged from hospital will be vaccinated with one intradermal injection of 0.1ml of BCG vaccine

BIOLOGICAL

Placebo

Patients discharged from hospital will be vaccinated with one intradermal injection of 0.1ml of sodium chloride 0.9%

Trial Locations (1)

12462

4th Department of Internal Medicine, ATTIKON University Hospital, Athens

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

lead

Hellenic Institute for the Study of Sepsis

OTHER

NCT03296423 - Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly | Biotech Hunter | Biotech Hunter